Previous research from our group used an unbiased pharmacogenomics approach and identified a remarkable correlation between NOTCH1 LOF mutations and sensitivity to PI3K inhibitors in HNSCC cell lines [87]. Here, PIK3CA is linked to head and neck squamous cell carcinoma.